Shumei Man Transmigration Across an in Vitro Blood-Brain Barrier CXCL 12-Induced Monocyte-Endothelial Interactions Promote Lymphocyte
暂无分享,去创建一个
[1] R. Ransohoff,et al. CXCR3-Dependent Plasma Blast Migration to the Central Nervous System during Viral Encephalomyelitis , 2011, Journal of Virology.
[2] David W. Holman,et al. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity , 2011, The Journal of experimental medicine.
[3] J. Rubenstein,et al. CXCR4 and CXCR7 Have Distinct Functions in Regulating Interneuron Migration , 2011, Neuron.
[4] T. Schall,et al. CXCR7 Protein Is Not Expressed on Human or Mouse Leukocytes , 2010, The Journal of Immunology.
[5] A. Mantovani,et al. Chemokine receptors intracellular trafficking. , 2010, Pharmacology & therapeutics.
[6] M. Weinand,et al. Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier , 2010, Nature Protocols.
[7] G. Luker,et al. Constitutive and Chemokine-dependent Internalization and Recycling of CXCR7 in Breast Cancer Cells to Degrade Chemokine Ligands , 2010, Oncogene.
[8] Y. Xiong,et al. Heterologous quaternary structure of CXCL12 and its relationship to the CC chemokine family , 2010, Proteins.
[9] R. Ransohoff,et al. Monocytes Regulate T Cell Migration through the Glia Limitans during Acute Viral Encephalitis , 2010, Journal of Virology.
[10] K. Dorovini‐Zis,et al. Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide , 2010, Journal of Neuroinflammation.
[11] H. Wekerle,et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions , 2009, Nature.
[12] R. Ransohoff. Immunology: In the beginning , 2009, Nature.
[13] G. Luker,et al. Imaging ligand-dependent activation of CXCR7. , 2009, Neoplasia.
[14] R. Klein,et al. IL-1R Signaling within the Central Nervous System Regulates CXCL12 Expression at the Blood-Brain Barrier and Disease Severity during Experimental Autoimmune Encephalomyelitis1 , 2009, The Journal of Immunology.
[15] R. Ransohoff,et al. α4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions , 2009, Journal of Neuroimmunology.
[16] R. Ransohoff,et al. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function , 2009, Neurology.
[17] M. Diamond,et al. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis , 2008, Proceedings of the National Academy of Sciences.
[18] Hosung Jung,et al. The Chemokine Stromal Cell-Derived Factor-1 Regulates GABAergic Inputs to Neural Progenitors in the Postnatal Dentate Gyrus , 2008, The Journal of Neuroscience.
[19] R. Schmidt,et al. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. , 2008, The American journal of pathology.
[20] R. Ransohoff,et al. Human Brain Microvascular Endothelial Cells and Umbilical Vein Endothelial Cells Differentially Facilitate Leukocyte Recruitment and Utilize Chemokines for T Cell Migration , 2008, Clinical & developmental immunology.
[21] R. Ransohoff,et al. Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology , 2008, Progress in Neurobiology.
[22] I. Campbell,et al. CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System1 , 2007, The Journal of Immunology.
[23] R. Ransohoff,et al. Natalizumab for multiple sclerosis. , 2007, The New England journal of medicine.
[24] Luca Cucullo,et al. Development of a Humanized In Vitro Blood–Brain Barrier Model to Screen for Brain Penetration of Antiepileptic Drugs , 2007, Epilepsia.
[25] S. Milano,et al. Regulation of receptor trafficking by GRKs and arrestins. , 2007, Annual review of physiology.
[26] R. Alon,et al. Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm. , 2007, Blood.
[27] R. Klein,et al. CXCL12 Limits Inflammation by Localizing Mononuclear Infiltrates to the Perivascular Space during Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.
[28] R. Rudick,et al. Chemokine Receptors as Biomarkers in Multiple Sclerosis , 2006, Disease markers.
[29] Kevin Wei,et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development , 2006, The Journal of experimental medicine.
[30] R. Ransohoff,et al. CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro. , 2006, Cellular immunology.
[31] B. Engelhardt. Molecular mechanisms involved in T cell migration across the blood–brain barrier , 2006, Journal of Neural Transmission.
[32] R. Ransohoff,et al. The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.
[33] B. Engelhardt,et al. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. , 2005, Trends in immunology.
[34] Cheng Dong,et al. Distinct role of hydrodynamic shear in leukocyte-facilitated tumor cell extravasation. , 2005, American journal of physiology. Cell physiology.
[35] Masami Niwa,et al. Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.
[36] R. Ransohoff,et al. CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer , 2004, Journal of Neuroimmunology.
[37] U. V. von Andrian,et al. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.
[38] R. Ransohoff,et al. Three or more routes for leukocyte migration into the central nervous system , 2003, Nature Reviews Immunology.
[39] Timothy N. C. Wells,et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[40] C. Culmsee,et al. A Dual Role for the SDF-1/CXCR4 Chemokine Receptor System in Adult Brain: Isoform-Selective Regulation of SDF-1 Expression Modulates CXCR4-Dependent Neuronal Plasticity and Cerebral Leukocyte Recruitment after Focal Ischemia , 2002, The Journal of Neuroscience.
[41] S. Cuvelier,et al. Shear-dependent Eosinophil Transmigration on Interleukin 4–stimulated Endothelial Cells , 2001, The Journal of experimental medicine.
[42] R. Ransohoff,et al. Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges. , 2001, Archives of neurology.
[43] R. Alon,et al. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines , 2001, Nature Immunology.
[44] R. Alon,et al. Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow , 2001, Journal of leukocyte biology.
[45] H. Weiner,et al. Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2) , 2000, The Journal of experimental medicine.
[46] W. Kuziel,et al. Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis , 2000, The Journal of experimental medicine.
[47] R. Hubbard,et al. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. , 1999, Biochemistry.
[48] M. Delepierre,et al. Stromal Cell-derived Factor-1α Associates with Heparan Sulfates through the First β-Strand of the Chemokine* , 1999, The Journal of Biological Chemistry.
[49] T. Springer,et al. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. , 1999, Immunity.
[50] Jakob S. Jensen,et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.
[51] F. Gilles,et al. Selective expression of adhesion molecules on human brain microvascular endothelial cells , 1997, Journal of Neuroimmunology.
[52] R. Hershkoviz,et al. Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta. , 1994, Journal of immunology.
[53] A. Huber,et al. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.
[54] G. Gray,et al. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. , 1991, Cancer research.
[55] Matthias Mack,et al. Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. , 2006, Brain : a journal of neurology.
[56] R. Ransohoff,et al. The expression and function of chemokines involved in CNS inflammation. , 2006, Trends in pharmacological sciences.
[57] C. Yiannoutsos,et al. SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. , 2003, Journal of neuropathology and experimental neurology.
[58] R. Klein,et al. SDF-1 α induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells , 2001 .
[59] E. Kaldjian,et al. Orchestrated information transfer underlying leukocyte endothelial interactions. , 1996, Annual review of immunology.
[60] A. Hudetz,et al. Heterogeneous autoregulation of cerebrocortical capillary flow: evidence for functional thoroughfare channels? , 1996, Microvascular research.
[61] D. Adams,et al. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. , 1993, Nature.
[62] Steffen Jung,et al. The FASEB Journal • Research Communication The neuronal chemokine CX3CL1/fractalkine , 2022 .